[Homozygous familial hypercholesterolemia. Response to combined cholestyramine and lovastatin therapy]

I Obando Santaella1, E Fernández Gómez, I Mongil Ruiz

  • 1Servicio de Pediatría, Hospital G B de Pozoblanco, Córdoba.

Insights

Homozygous familial hypercholesterolemia (FH) is a severe genetic disorder. A combination therapy of lovastatin and cholestyramine effectively reduced cholesterol levels by 67% in a patient with FH.

Area of Science:

  • Cardiology
  • Genetics
  • Biochemistry

Background:

  • Familial hypercholesterolemia (FH) is an inherited disorder characterized by high levels of low-density lipoprotein (LDL) cholesterol.
  • Homozygous FH results from genetic defects in the LDL receptor, leading to severe hypercholesterolemia and premature cardiovascular disease.
  • Standard drug therapies are often ineffective in patients with homozygous FH.

Observation:

  • A patient with receptor-defective homozygous FH was treated with a combination regimen.
  • The treatment involved lovastatin and cholestyramine.
  • A 7-month follow-up period was conducted.

Findings:

  • The combined drug regimen resulted in a significant reduction in cholesterol levels by 67%.
  • Adverse events related to the treatment were observed during the follow-up period.

Implications:

  • Combined drug therapy may be a promising treatment option for patients with homozygous FH, particularly those with residual receptor activity.
  • Further research is needed to optimize treatment strategies and manage adverse events in homozygous FH.
  • This case highlights the potential of combination therapy in managing severe genetic lipid disorders.

Related Concept Videos

Lipid Digestion01:06

Lipid Digestion

Lipids are large molecules that are generally not water-soluble. Since most of the digestive enzymes in the human body are water-based, there are specific steps the body must take to break down lipids and make them available for use.
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Lipid Catabolism01:25

Lipid Catabolism

Triglycerides serve as crucial long-term energy storage molecules in microorganisms, providing a dense source of metabolic energy. Their breakdown is mediated by lipases, which hydrolyze triglycerides into glycerol and free fatty acids. Each of these components follows distinct metabolic pathways, ultimately contributing to ATP synthesis and cellular energy homeostasis.Glycerol MetabolismGlycerol, released from triglyceride hydrolysis, is phosphorylated by glycerol kinase to form...